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Second hand smoke (SHS) introduces thousands of toxic chemicals into the lung, including
carcinogens and oxidants, which cause direct airway epithelium tissue destruction.
It can also illicit indirect damage through its effect on signaling pathways related to
tissue cell repair and by the abnormal induction of inflammation into the lung. After
repeated exposure to SHS, these symptoms can lead to the development of pulmonary
inflammatory disorders, including chronic obstructive pulmonary disease (COPD). COPD
is a severe pulmonary disease characterized by chronic inflammation and irreversible
tissue destruction. There is no causal cure, as the mechanism behind the development
and progression of the disease is still unknown. Recent discoveries implicate genetic
predisposition associated with inflammatory response contributed to the development
of COPD, linked to irregular innate and adaptive immunity, as well as a risk factor for
cancer. The use of animal models for both cigarette smoke (CS) and SHS associated in vivo
experiments has been crucial in elucidating the pathogenic mechanisms and genetic
components involved in inflammation-related development of COPD.
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CLASSIFICATION OF SHS
Second hand smoke (SHS) is classified as exposure to sidestream
smoke, produced directly by tobacco containing products
(cigarettes, cigars, and pipes), or mainstream smoke, exhaled by
smokers. The US Environmental Protection Agency determined
in 1986 that SHS is a cause of lung cancer development, respon-
sible for approximately 3000 lung cancer deaths annually (Jinot
and Bayard, 1994; IARC, 2004; Talhout et al., 2011). In 2010,
there were 10.3% adult smokers worldwide, or 45.3 million peo-
ple, so the frequency of SHS exposure can be extensive (King
et al., 2011). Around 10–25% of lung cancers are diagnosed in
nonsmokers, who are considered to have smoked less than 100
cigarettes in their lifetime (Couraud et al., 2012). Evidence for
the toxicity of SHS was found in non-smoking individuals with
spouses who smoked cigarettes, who displayed elevated risks for
lung cancer, heart disease, and respiratory disorders (HHS, 2006;
Sebelius, 2011).
The burning tip of a cigarette is hot enough to allow for
the release of tobacco smoke (TS) components into a gas and
particulate vapor that is easily absorbed into the lung (Pappas,
2011; Talhout et al., 2011). This vapor rapidly enters the lower
airways of the human lung, and eventually the circulatory and
lymphatic systems (IARC, 2004; Baker, 2006). While tobacco is
comprised of more than 5000 constituents, TS contains roughly
2800 molecules not found in tobacco, including reactive oxy-
gen species (ROS) and nitric oxides (Baker, 2006). This indicates
that the combustion, pyrolysis, and prosynthetic reactions during
the flaming of the tobacco product are what create the compo-
nents of TS (Baker, 2006). Approximately 250 carcinogenic and
noxious chemicals have been measured in both sidestream and
mainstream smoke (HHS, 2006). Mainstream smoke is generated
at high temperatures in the presence of oxygen drawn through
the column of a smoking apparatus, resulting in larger particles
than sidestream smoke (HHS, 2006). Sidestream smoke is gener-
ated at lower temperatures in an oxygen-poor environment, with
higher concentrations of ammonia, nitric oxides, and carcinogens
(HHS, 2006). While all forms of environmental TS exposure have
been shown to cause genetic damage, the detriments of SHS to
a person vary based on proximity to source of smoke, time, and
environment.
SHS-INDUCED INFLAMMATION AND COPD
In response to SHS exposure, there is enhanced recruitment
of inflammatory cells to the lung, particularly neutrophils and
macrophages (Rennard et al., 2006). Short-term exposure to
SHS does not result in a notable difference in inflammation in
humans, though endothelial function deteriorates (Bonetti et al.,
2011). Long-term TS exposure in mice leads to significantly
increased inflammation, as measured by the influx of alveo-
lar macrophages, neutrophils, and antioxidant enzymes (Bezerra
et al., 2011). TS can also directly bind to DNA to effect the expres-
sion of genes related to inflammation. Sekhon et al. determined
that nicotine can enter the placenta and directly interact with
nicotine receptors on non-neuronal cells of the fetus (Sekhon
et al., 1999). They also found that nicotine exposure leads to the
enhancement of elastin and collagen type I and III mRNA expres-
sion, as well as airway wall expansion in the fetal lung (Sekhon
et al., 2002).
SHS increases the incidence and severity of respiratory infec-
tions and disorders in humans (Jinot and Bayard, 1994; HHS,
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2006; Sebelius, 2011). Exposure to TS introduces thousands of
xenobiotics to the lung, and can lead to a persistent inflammatory
response in the small airways and alveoli. This is the founda-
tion for the development of pulmonary inflammatory disorders,
such as COPD. COPD is a progressive and irreversible airflow
obstructive disease of the lung and the third leading cause of
death in the US. Of patients who are diagnosed with lung can-
cer, 40–70% of patients have COPD (Young et al., 2009). Chronic
bronchitis, characterized by a consistent cough with mucus secre-
tion, and emphysema, characterized by the destruction of airway
epithelium and thickening of airway walls, is the distinct phe-
notypes that define COPD, though they can occur concurrently.
Manifestation of COPD is a result of an interaction of TS expo-
sure with other toxic environmental exposures, genetic factors,
and unresolved childhood respiratory infections (Decramer et al.,
2012). While TS is the main risk factor for COPD, only 20%
of smokers develop COPD, suggesting a genetic predisposition
(Young et al., 2009). Evidence for this includes the discovery of
the genetic variants and mutations associated with TS-induced
inflammation and COPD (Gwilt et al., 2007; Guo et al., 2012;
Hunt and Tuder, 2012). These polymorphisms and mutations
may be responsible for the exacerbation of inflammatory symp-
toms, resulting in COPD and lung cancer development (Young
et al., 2009).
One of the most damaging effects of TS is oxidative dam-
age, which promotes COPDdevelopment (Decramer et al., 2012).
SHS contains >1016 free radicals per cigarette (Barcelo et al.,
2008), comprising of ROS and peroxides (Baker, 2006). When
introduced to the lung, an imbalance of oxidant and antioxidants,
which protect against free radicals, occurs and results in oxida-
tive stress (HHS, 2006). Oxidative stress induces direct airway
epithelial damage, as well as indirect damage by altering signal-
ing pathways. These pathways are related to cell proliferation,
differentiation, and proinflammatory cytokines and chemokines
through the upregulation of the transcription factors nuclear
factor-κB (NF-κB) and activator-protein 1 (AP-1) (MacNee,
2001; HHS, 2006). Oxidative stress also leads to the oxidation
of DNA, lipids, and proteins, resulting in lung injury and the
production of secondary ROS (MacNee, 2001). Additionally, it
can prevent repair processes in the damaged epithelium through
inhibition or damage to surfactant and antiproteases, which leads
to the development of fibrosis (MacNee, 2001; Decramer et al.,
2012). Howard et al. developed a short-term SHS rat model and
found considerable DNA damage in several tissues, measured
by the presence of 8-hydroxy-2′-deoxyguanosine (8-OHdG), a
major product of DNA oxidation (Howard et al., 1998). Chiang
et al. found that 8-OHdG levels in human plasma increases
with SHS exposure in a dose-dependent manor (Chiang et al.,
2012).
Both the innate and adaptive immune responses play a role
in the pathogenesis of COPD. In response to SHS, the innate
immune response is triggered, resulting in inflammatory cell infil-
tration, mainly neutrophils and macrophages, to the mucosa and
submucosa glands of the airway epithelium (van Antwerpen et al.,
1995; MacNee, 2001; Decramer et al., 2012). Neutrophils and
macrophages release neutrophil elastase and macrophage met-
alloproteases, respectively, along with pro-apoptotic factors to
combat toxins and prevent the spread of injury. Accumulation of
activated inflammatory cells from repeated SHS exposure reduces
their usefulness, resulting in tissue damage and oxidative stress
(Bosken et al., 1991; Rennard et al., 2006). This exacerbates TS-
induced airway destruction, fibrosis, and remodeling, which are
the basis for the development of inflammatory disorders (Bosken
et al., 1991; Rennard et al., 2006).
TS can enhance the damaging phenotype of inflammatory
cells. In study participants exposed to 3 hours of sidestream
smoke, there was an average of 71% more reactive oxidants
released by neutrophils (Anderson et al., 1991). Furthermore,
activated polymorphonuclear cells are delayed in the lung
microvessels by TS, allowing for enhanced tissue destruction
(Klut et al., 1993). A positive correlation has been found with
higher numbers of neutrophils in the circulating blood and
reduced airway function, measured by spirometric levels (FEV1),
in smoker lungs (van Antwerpen et al., 1995).
Dendritic cells are the link between the innate and adaptive
immunity. If the innate immune response is unable to control
the damage by TS, the recruited inflammatory cells, cytokines,
chemokines, antigens, and other factors can induce dendritic
cells to migrate to the lymphnodes for activation and differen-
tiation (Cosio, 2004). Dendritic cells interact with T-cells and
B-cells to instigate and shape the adaptive immune response.
Naïve T-cells differentiate into several subsets, including T-helper
1 (Th1), T-Helper 2 (Th2), T-helper 17 (Th17), and regulatory
T cells (Treg). These are distinct in the T-cell factors and cytokines
they activate. The differentiation is largely dependent on the local
inflammatory environment and the strength of the T cell recep-
tor with the antigen (Zhou et al., 2009). The characteristic of the
T-cells in disease manifestation and progression is important to
consider, because the imbalance of T-cell populations can lead
to irregular and severe inflammatory responses. Further analy-
sis into the inflammatory microenvironment of the COPD lung
has led to the discovery that the Th1 (Grumelli et al., 2004; Lee
et al., 2007) and Th17 (Vargas-Rojas et al., 2011) subsets are par-
ticularly high in the COPD lung, with Th17 cells conceivably
mediating the Th1 activity (Alcorn et al., 2010; Vanaudenaerde
et al., 2011). Chen et al. exposed wild-type and IL-17Ra defi-
cient mice to sidestream smoke for 6 months and found that the
deficient mice developed significantly less tissue emphysema and
airspace enlargement (Chen et al., 2011).
In addition, Tregs are absent in the bronchoalveolar lavage
(BAL) fluid and blood of COPD patients (Lee et al., 2007; Barcelo
et al., 2008), while smokers without COPD show an upregu-
lation of this subtype (Barcelo et al., 2008). Tregs are critical
in containing the immune response and maintaining tolerance
to self-antigens. Therefore, without Treg regulation, continual
exposure to TS can lead to an overpowering pro-inflammatory
response mediated by Th1 and Th17 lymphocytes, resulting in
the severe airway damage characterized by COPD.
B-cells have also been found to be upregulated in TS-driven
emphysema patients. B-cell follicles were found in the bronchial
walls and parenchyma of these patients and increased over time,
which correlated with progressive airspace enlargement (van der
Strate et al., 2006). While exposure to TS illicits airway damage
and subsequent release of antigens by the innate immune system
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in all lungs, not all people react to the antigens and have resulting
B- and T-cell differentiation, which explains why only a percent-
age of smokers develop COPD (Cosio et al., 2009). There is also
a variation in the degree in which people react to the antigens,
which explains the deviation in severity of the disease (Cosio et al.,
2009).
Of growing interest is the hypothesis that COPD is linked
to autoimmunity. Reduced levels of Tregs are an indication of
autoimmunity (Shevach, 2000). Also, in order for T-cells to
migrate to the lung, they must be activated by antigens (self or
modified-self) (Cosio, 2004). Lee et al. discovered that antibod-
ies toward elastin, a self-antigen, were significantly increased in
emphysema patients (Lee et al., 2007). They propose TS-exposure
leads to proteolytic-induced cleavage of elastin, resulting in frag-
ments that generate T- and B-cell immunity against elastin (Lee
et al., 2007). Kirkham et al. propose that chronic oxidative stress
in COPD induces carbonyl-modification of self-proteins, creating
neoantigens that are targeted by the immune system. In support
of this hypothesis, they found increased antibody titer against
carbonyl-modified self-proteins in COPD patients versus control
subjects (Kirkham et al., 2011). Additionally, the persistence of
COPD symptoms after smoking cessation indicates that T- and B-
cells are recruited in response to self-antigens (Motz et al., 2008;
Cosio et al., 2009).
INFLAMMATION AND CANCER
The enhanced inflammatory cell environment of the lung from
exposure to TS can promote the development of mutated
cells into malignant cells, eventually resulting in tumor forma-
tion and progression. While acute inflammation inhibits tumor
growth, long-term inflammation promotes tumor enlargement
andmetastasis. Because TS can compromise alveolar repair mech-
anisms, such as chemotaxis, apoptosis, and matrix restoration,
these malignant cells can develop into tumors and metastasize
(Rennard et al., 2006). Jinushi et al. generated genetically modi-
fiedmice study the relationship of chronic inflammation and lung
cancer by simulating defects in apoptotic cell clearance, autoreac-
tive Th17, and increased vulnerability to infection (Jinushi et al.,
2007). These mice developed chronic pulmonary inflammation
and lung adenocarcinomas, as well as increasedmortality (Jinushi
et al., 2007).
The main link between chronic inflammation and oncogene-
sis is considered to be TNF-α mediated upregulation of NF-κB,
which induces anti-apoptotic and proliferative effects. TNF-α has
a seemingly contradictory role of stimulating apoptosis through
activation of caspase 8, while simultaneously activating NF-κB,
which protects cells from pro-apoptotic stimuli. NF-κB is a tran-
scription factor which plays an integral role in the immune
response to infection. It is activated by cellular signals resulting
from stimuli such as necrotic cells, cytokines, and ROS. Once
activated, NF-κB translocates into the nucleus to bind to DNA,
activating hundreds of different genes encoding proteins related
to the immune response, inflammation, and cell growth. In an
environment of pre-malignant cells due to environmental expo-
sures like SHS, continual NF-κB activation will support tumor
development and progression by inhibiting apoptosis while acti-
vating cell proliferation, metastasis, and survival through the
products of genes it regulates (Karin et al., 2002; Luo et al., 2004;
Philip et al., 2004; Karin, 2006).
In addition to TNF-α, there are other molecular pathways
implicated in upregulating NF-κB expression and other transcrip-
tion factors (TFs). Zhao et al. used protein and DNA arrays to
examine potential upstream signaling pathways responsible for
TS-induced TF activation. By exposing cells to TS, they examined
244 different TFs. TS significantly regulates at least 20 TFs includ-
ing NF-κB, which may be involved in tumorigenesis and cell
cycle regulation, activated primarily by MAPK signaling pathways
(Zhao et al., 2007). These results indicate that MAPK signaling
is also essential in TS-induced NF-κB activation and subsequent
inflammatory gene expression.
The long-term use of anti-inflammatory agents have been
linked to decreased cancer incidence, indicating inflammation
as a contributor to cancer development (Dougan et al., 2011).
Witschi et al. exposed mice both mainstream and sidestream
smoke for 5 months, followed by a 4 month recovery period
(Witschi et al., 2005). When mice were introduced to dexam-
ethasone, an anti-inflammatory and immunosuppressant gluco-
corticoid steroid drug, for 4 months, the lung tumor multiplicity
decreased by 64% compared to control mice (Witschi et al.,
2005).
COPD is believed to be an independent risk factor for lung
cancer. Prevalence of COPD in lung cancer cases is six-fold higher
than in smokers without lung cancer (Young et al., 2009). Because
chronic airway inflammation is a risk factor for COPD and is
related to the increase of human cancers, it is hypothesized that
COPD and lung cancer may share chronic inflammation as a
common pathogenic mechanism (Young et al., 2009).
USE OF ANIMAL MODELS
Animal models continue to be crucial in determining the
genetic factors underlying SHS and COPD (Table 1). When
considering mouse models for experimental use, the choice of
strain is critical in studies related to both SHS and COPD
as there are strain-related differences in the metabolism of TS
as well as the inflammatory cell composition and magnitude.
Vecchio et al. examined this issue by comparing C57BL/6J and
Institute of Cancer Research (ICR) mice post-cigarette smoke
extract exposure (Vecchio et al., 2010). They found that alve-
olar macrophages from C57BL/6J mice produced higher lev-
els of ROS, NF-κB, and proinflammatory cytokines (Vecchio
et al., 2010). They hypothesize that the higher pro-inflammatory
response in C57BL/6J versus ISC mice is due to higher oxida-
tive stress in this strain, leading to increased activation of NF-
κB. This may describe the differences in susceptibility of the
different strains of mice (Vecchio et al., 2010). Cavarra et al.
found that after acute TS exposure, DBA/2 and C57BL/6J mice
had decreased antioxidant defenses, measured in bronchoalve-
olar lavage fluid, while ICR mice had increased antioxidants
(Cavarra et al., 2001). After chronic exposure to TS for 7
months, they found that DBA/2 and C57BL/6J mice are more
likely to develop emphysema and decreased lung elastin lev-
els, while ICR mice did not develop these phenotypes (Cavarra
et al., 2001). Tsuji et al. compared CS-exposure in AKR/J and
C57BL/6J mice and found that C57BL/6J mice inhaled higher
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Table 1 | Factors that influence SHS-induced COPD development and progression.
Exposure Factor Role in COPD development Animal model Strain background References
Lipopolysacharide Acetylcholine Airway remodeling and emphysema Guinea pig Dunkin Hartley Pera et al., 2011
Cigarette smoke
Extract
Akt serine/threonine
protein kinase (Akt)
Reduces cytotoxicity of TS,
TS-exposure causes ubiquination of
Akt
Rat Lewis Kim et al., 2011
Cigarette smoke Caspase 1 (Casp1) Inflammatory cell influx through
IL-1β/IL-18
Mouse C57BL/6 Churg et al., 2009
Cigarette smoke C-Jun/Activator protein 1
(AP-1)
Regulates inflammation after
long-term SHS exposure, restrains
emphysema symptoms
Mouse C57BL/6 × 129SVJ Reddy et al., 2012
Cigarette smoke Clara cell 10 kDa (Ccsp) Protects the airway epithelium, TS
exposure causes metaplasia of
clara cells
Mouse BALB/c Cuzic et al., 2012
Cigarette smoke Chemokine (C-X3-C)
receptor 1 (Cx3cr1)
Required for IL-6 and TNF-α
production by phagocytes;
development of emphysema
phenotype
Mouse C57BL/6 Xiong et al., 2011
Cigarette smoke Early growth response-1
(Egr-1)
Promotes autophagy and apoptosis
in early stages of COPD
Mouse C57BL/6 Chen et al., 2008
Cigarette smoke endothelial
monocyte-activating
protein 2 (EmapII)
Inducing apoptosis through caspase
3, macrophage influx, emphysema
phenotype
Mouse C57BL/6 Clauss et al., 2011
Cigarette smoke Extracellular
signal-regulated kinase
1/2 (Erk 1/2)
Airway mucus hypersecretion Rat Sprague-Dawley Xiao et al., 2011
Cigarette smoke Extracellular superoxide
dismutase (Ecsod)
Reduces TS-induced oxidative
stress
Mouse C57BL/6 Tollefson et al.,
2010
Cigarette smoke Forkhead box O3 (Foxo3) Regulates inflammation, antioxidant
genes; downregulated in COPD
Mouse FVBx129S6 Hwang et al.,
2011
Cigarette smoke Granulocyte/Macrophage
colony–stimulating factor
(Gm-CSf)
Initiation of inflammatory cell influx Mouse BALB/c Vlahos et al., 2010
Cigarette smoke IFN regulatory factor
(Irf7)
Inhibited in COPD lung, dampens
proinflammatory cytokines in lung
dendritic cells
Mouse C57BL/6 Shan et al., 2012
Overexpression
of IL-11 through
transgenic mouse
model
Interleukin 11 (Il-11) Emphysema phenotype, airway
remodeling and fibrosis
Mouse Not reported Kuhn et al., 2000
Cigarette smoke
extract
Interleukin 17 Receptor
A (Il-17RA)
Induces matrix metalloproteinase
-12 (MMP-12) and CCl2, required for
emphysema development
Mouse C57BL/6 Chen et al., 2011
Cigarette smoke Interleukin 1 Receptor,
Type 1 (Il1R1)
Critical in initiation of neutrophilic
inflammatory response to
short-term TS
Mouse C57BL/6 Doz et al., 2008
Cigarette smoke Interleukin 1 alpha (Il-1α) Critical in the initiation of the
neutrophilic inflammatory response
to TS
Mouse BALB/c Botelho et al.,
2011
Overexpression
of IL1-β through
transgenic mouse
model
Interleukin 1 beta (Il1-β) Macrophage and neutrophil influx,
emphysema phenotype
Mouse Not reported Lappalainen
et al., 2005
(continued)
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Table 1 | Continued
Exposure Factor Role in COPD development Animal model Strain background References
Overexpression
of IL-6 through
transgenic mouse
model
Interleukin 6 (Il-6) Emphysema phenotype, airway
remodeling and fibrosis
Mouse Not reported Kuhn et al., 2000
Cigarette smoke Mucin-5ac (Muc5ac) Mucus secretion in response to
pro-inflammatory cytokines
Rat Sprague-Dawley Xiao et al., 2011
Cigarette smoke NADPH oxidase (Nox) Highly expressed in neutrophils,
source of oxidative stress
Mouse C57BL/6 Tollefson et al., 2010
Cigarette smoke Osteopontin (Opn) Th17 differentiation, emphysema
phenotype
Mouse C57BL/6 Shan et al., 2012
Cigarette smoke P2X7 Neutrophil influx, caspase 1 activity,
IL-1β
Mouse C57BL/6 Eltom et al., 2011
Lipopolysacharide
and cigarette
smoke
Peroxisome
proliferator-activated
receptor-gamma
(Pparγ)/PPARγ
coactivator-1α (Pgc-1α)
Relieves oxidative stress;
expression decreases with
progression of COPD
Rat Sprague-Dawley Li et al., 2010
Cigarette smoke Transforming growth
factor beta (Tgf-β)
Airway remodeling, emphysema
phenotype
Mouse AKR/J, C57BL/6 Podowski et al., 2012
Cigarette smoke Toll-like receptor 4 (Tlr4) Critical in the initiation of the
neutrophilic inflammatory response
to TS short-term (61, 63); Role is
diminished in chronic TS-exposure
model (61)
Mouse C3H/HeJ (Maes),
C57BL/6J (Doz)
Maes et al., 2006;
Doz et al., 2008
Cigarette smoke Toll-like receptor 4 (Tlr4) Induces Metalloproteinase-1
(MMP-1), required for emphysema
development
Mouse, Rabbit C57BL/CBA, New
Zealand White
Geraghty et al., 2011
Cigarette smoke Tumor necrosis
factor-alpha (Tnf-α)
Inflammatory cell influx, chronic
inflammation, emphysema
phenotype
Mouse C57BL/6 Churg et al., 2004
Knock-out genetic
model
Vascular endothelial
growth factor (Vegf)
Preventative role in emphysema Mouse C57BL/6 Tang et al., 2004
Listed in alphabetical order are proteins, receptors, and other factors which have been discovered in animal models that influence SHS-induced COPD. Their degree
of influence in vivo could vary based on the experimental design; therefore the exposure models and mouse strains are also included in the table.
amounts of smoke and more severe respiratory lesions, while
AKR/J mice had higher inflammatory cytokine levels (Tsuji et al.,
2011).
Our lab developed a mouse model to simulate the devel-
opment of COPD and SHS (Birru et al., 2012). We sep-
arated mice into four treatment groups: filtered-air control,
lipopolysacharide (LPS) to stimulate inflammation, CS, and LPS
combined with CS. Mice were sacrificed after 6 months of
weekly LPS and daily CS exposure. The inflammatory response,
alveolar space enlargement, and lung tumor incidence were
assessed. In the LPS only group, mice displayed increased inflam-
mation, but no alveolar space enlargement (Figure 1). In the
LPS and CS group, mice displayed enhanced inflammation and
alveolar space enlargement compared to the CS only group
(Figure 1). No groups developed tumors in this exposure model
at the duration examined. Our results indicate that chronic
inflammation enhances emphysema-like alveolar space enlarge-
ment.
We also developed an animal exposure paradigm using com-
ponents of TS to determine the role of inflammation in the
development and progression of tumor formation (Keohavong
et al., 2011). We used LPS to incite inflammation and nicotine-
derived nitrosamine (NNK) for tumorigenesis (14). Mice were
assigned into four different treatment groups: saline control, LPS
only, NNK only, and LPS combined with NNK for 4 months. The
saline and LPS only groups had no tumor development, but there
was a six-fold increase in tumor numbers in the LPS and NNK
group compared to the NNK only group. The LPS only and LPS
with NNK groups displayed significantly elevated inflammation
compared to the saline andNNKonly groups. Our results indicate
that repeated exposure to inflammation enhances the progression
of TS carcinogen-induced lung tumorigenesis.
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FIGURE 1 | TS and LPS treated mice have enhanced inflammation
and alveolar space enlargement.Mice were exposed to filtered air (A,B)
or TS (C,D) generated by Kentucky Research Cigarettes for 6 months.
Inflammation was further induced by intranasal LPS instillation (B,D), with
saline as a control (A,C). Lung histology was analyzed by staining lung
sections with hematoxylin and eosin. Results shown are representative
images for each treatment at 10X magnification. TS-exposed mice
displayed alveolar space enlargement (C) compared to filtered air exposure
(A). LPS stimulated inflammatory cell influx (B) and enhanced the alveolar
space enlargement induced by TS (D) relative to TS-only exposure (C).
CONCLUSIONS
SHS exposure is detrimental to the lung, resulting in lung
destruction through the introduction of toxic chemicals to
the lung and oxidants, as well as the inhibiting the repair
pathways of the lung. Continued SHS exposure can also lead
to the development of inflammation, which worsen COPD,
due to the abnormal polarization of T- and B-cell differen-
tiation. The enhanced inflammatory environment of the lung
can also promote tumor initiation and progression of malig-
nant cells through the activation of transcription factors that
promote cell proliferation and inhibit apoptosis. Both envi-
ronmental factors and genetic components underlying COPD
continue to be uncovered, and will be crucial in developing use-
ful treatments for the disease. Animal models for SHS-driven
COPD studies will continue to play an essential role for this
objective.
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